Project Details
Description
Researchers at the Mayo Clinic are investigating the importance of a molecule called PAR1 in myelin protection and repair to determine if currently approved drugs that target PAR1 for treatment of other diseases could be used to treat people with MS.
| Status | Finished |
|---|---|
| Effective start/end date | 4/1/15 → 3/31/18 |
Funding
- National Multiple Sclerosis Society: $607,111.00
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.